Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Romain Fournier

Chief Editor
Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.

Analyst recommendations: Amgen, Banner, Merck, Oracle, Phoenix...

09/07/2021 | 07:44am EDT

Every day, find a selection of analysts' recommendations covering North America and the U.K. The list only includes companies that have been the subject of a change of opinion or price target, or a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain shares or the market sentiment on a company.

 

  • Admiral: JPMorgan  reduced the price target of Admiral Group to 27.10 pounds sterling from 27.30 pounds and reiterated its neutral rating.
  • Amgen: Morgan Stanley cut its recommendation to equal-weight from overweight. PT rises 10% to $85
  • Asos: Goldman Sachs is keeping its Buy rating. The target price is reduced from GBp 6100 to GBp 5800.
  • Banner: D.A. Davidson & Co downgrades Banner Corp. to neutral from buy. PT up 6.2 % to $60
  • Cirrus Logic:  Barclays upgrades to overweight from equal-weight. PT gains 20% to $100
  • EnQuest: Jefferies upgraded from buy to hold with a target of 24 GBp. 
  • Merck & Co: Morgan Stanley downgrades to equal-weight from overweight. PT up 10% to $85
  • Oracle: Jefferies retains its Neutral opinion on the stock. The target price has been revised upwards and is now set at USD 95, compared with USD 80 previously.
  • Phoenix group: JPMorgan lowered the price target of Phoenix Group to 7.09 pounds sterling from 7.93 pounds and maintained its neutral rating.

© MarketScreener.com 2021